Pharmacokinetics and Bioequivalence Evaluation of 2 Formulations of Tenofovir Alafenamide.

导出 LinkOut

翻译打印收藏纠错

作者： Zhihui,Li ^[1] ; Jingyan,Liu ^[1] ; Gehang,Ju ^[1] ; Keyu,Yan ^[1] ; Yong,Mao ^[2] ; Qingchun,Liu ^[2] ; Xinlu,Yang ^[2] ; Rong,Zhang ^[3] ; Wen,Qiu ^[4]

作者单位： School of Pharmacy Lanzhou University, Lanzhou University, Lanzhou, China. ^[1] Chengdu Brilliant Pharmaceutical Co., Ltd, Chengdu, China. ^[2] The Laboratory of Bioanalysis, Chengdu Fanweixi Pharmaceutical Technology Co., Ltd., Chengdu, China. ^[3] Phase I Clinical Unit, Lanzhou University Second Hospital, Lanzhou, China. ^[4]

关键词 bioequivalence pharmacokinetics tenofovir alafenamide

主题词丙氨酸(Alanine);曲线下面积(Area Under Curve);交叉研究(Cross-Over Studies);人类(Humans);片剂(Tablets);治疗等效(Therapeutic Equivalency)

DOI 10.1002/cpdd.985

PMID 34352149

发布时间 2022-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical pharmacology in drug development

2021年10卷12期

1519-1527页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetics and Bioequivalence Evaluation of 2 Formulations of Tenofovir Alafenamide.

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetics and Bioequivalence Evaluation of 2 Formulations of Tenofovir Alafenamide.

Clinical pharmacology in drug development

相似文献

Clinical pharmacology in drug development

相关期刊

检索历史清除